Clinical trial
Drug Interaction Potential of Pro-Inflammatory Conditions
NCT07360938 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Drug Interaction Potential of Pro-Inflammatory Conditions
- Lead sponsor
- Indiana University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 1, 2025
- Completion date
- December 31, 2030
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, type 2, end stage renal disease, irritable bowel syndrome